Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Psoriasis Patients with Unsatisfactory DMARD Response
NCT02258282Unknown
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- May 2014
- Primary completion
- Dec 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Randomised trial of etanercept in psoriasis, sponsored by General Hospital of Western Theater Command of PLA. Primary endpoint: Physician's Global Assessment at 24 weeks. Status: unknown.
02
Drugs
etanercept
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02258282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02258282.